Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Scurria scurra

ABSTRACT: Scurria scurra Genome sequencing

PROVIDER: PRJNA1047495 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR27088385_subreads.fastq.gz	Fastqsanger.gz
	SRR30640722.fastq.gz	Fastqsanger.gz
	SRR30640722_1.fastq.gz	Fastqsanger.gz
	SRR30640722_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5

Similar Datasets

Scurria scurra

Project description:Scurria scurra overview

| PRJNA806323 | ENA

Scurria scurra

Project description:Scurria scurra Genome sequencing and assembly

| PRJNA794077 | ENA

Scurria viridula

Project description:Scurria viridula Genome sequencing

| PRJNA1047508 | ENA

Scurria zebrina

Project description:Scurria zebrina Genome sequencing

| PRJNA1047498 | ENA

Scurria scurra, Scurria variabilis, Scurria araucana, Scurria ceciliana

Project description:Comparative population genomics of congeneric Scurria limpets

| PRJNA944965 | ENA

Project description:DNBseq of Scurria scurra

| PRJNA1190503 | ENA

Scurria

Project description:Identification of hybridization between Scurria viridula and S. zebrina along the Chilean Coast using genotyping by sequencing

| PRJNA825578 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Project description:Keyacris scurra population genetics

| PRJNA702007 | ENA

Project description:RNAseq Scurria zebrina

| PRJNA1068979 | ENA